Haythem Ali
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Advanced Breast Cancer Therapies 5
- Digital Radiography and Breast Imaging 4
- Prostate Cancer Treatment and Research 4
- Oncology 18
- Global Cancer Incidence and Screening 5
- Co-authors
- Ezra E.W. Cohen (4 shared papers)Lori J. Wirth (4 shared papers)Rossella Elisei (4 shared papers)Steven I. Sherman (4 shared papers)Barry D. Nelkin (4 shared papers)Lisa Licitra (4 shared papers)Douglas W. Ball (4 shared papers)Marcia S. Brose (4 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Annals of Oncology (3 papers)Cancer Research (3 papers)Cancer Epidemiology Biomarkers & Prevention (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Haythem Ali
51 papers receiving 1.8k citations
Haythem Ali's Hit Papers
Peers
Comparison fields: 5 of 99
- Endocrinology, Diabetes and Metabolism 612
- Oncology 591
- Cancer Research 243
- Otorhinolaryngology 51
- Pulmonary and Respiratory Medicine 367
Countries citing papers authored by Haythem Ali
This map shows the geographic impact of Haythem Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haythem Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haythem Ali more than expected).
Fields of papers citing papers by Haythem Ali
This network shows the impact of papers produced by Haythem Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haythem Ali. The network helps show where Haythem Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Haythem Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cabozantinib in Progressive Medullary Thyroid Cancer Hit paper breakdown → | 2013 | 860 |
| 2 | 2017 | 177 | |
| 3 | 2018 | 93 | |
| 4 | 2012 | 69 | |
| 5 | 2016 | 63 | |
| 6 | 2016 | 55 | |
| 7 | 2019 | 47 | |
| 8 | 2019 | 47 | |
| 9 | Chemotherapy in advanced nasopharyngeal cancer. | 2000 | 41 |
| 10 | 2018 | 35 | |
| 11 | 2020 | 28 | |
| 12 | 2015 | 23 | |
| 13 | 2018 | 21 | |
| 14 | 2018 | 19 | |
| 15 | 2017 | 16 | |
| 16 | 2023 | 16 | |
| 17 | 2012 | 14 | |
| 18 | 2019 | 14 | |
| 19 | 2012 | 14 | |
| 20 | 2015 | 13 |
About Haythem Ali
Haythem Ali is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Otorhinolaryngology, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Head and Neck Cancer Studies (5 papers), Advanced Breast Cancer Therapies (5 papers), Global Cancer Incidence and Screening (5 papers), Digital Radiography and Breast Imaging (4 papers), Prostate Cancer Treatment and Research (4 papers), AI in cancer detection (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (612 citations), Oncology (591 citations), Cancer Research (243 citations), Otorhinolaryngology (51 citations) and Pulmonary and Respiratory Medicine (367 citations). Haythem Ali has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ezra E.W. Cohen, Lori J. Wirth, Rossella Elisei, Steven I. Sherman, Barry D. Nelkin, Lisa Licitra, Douglas W. Ball, Marcia S. Brose, Patrick Schöffski and Stefan Müller. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancer Epidemiology Biomarkers & Prevention and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.